Erik Corcoran Selected Research

Erik Corcoran Research Topics

8	Neoplasms (Cancer) 12/2017 - 03/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2009 - 01/2009
2	Hypoxia (Hypoxemia) 06/2009 - 04/2006
2	Infections 01/2008 - 05/2006
1	Hepatocellular Carcinoma (Hepatoma) 12/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2011
1	Exanthema (Rash) 07/2009
1	Inflammation (Inflammations) 07/2009
1	Neoplasm Metastasis (Metastasis) 06/2009
1	Colorectal Neoplasms (Colorectal Cancer) 06/2009
1	Body Weight (Weight, Body) 01/2008
1	Pathologic Neovascularization 11/2006
1	Breast Neoplasms (Breast Cancer) 11/2006
1	Sepsis (Septicemia) 05/2006

4	ErbB Receptors (EGF Receptor)IBA 07/2009 - 04/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 04/2006
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2011 - 01/2009
3	Monoclonal AntibodiesIBA 07/2009 - 03/2005
3	AntibodiesIBA 06/2009 - 11/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2011 - 03/2005
2	Cetuximab (Erbitux)FDA Link 06/2009 - 04/2006
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2017
1	palbociclibIBA 12/2017
1	H3B-6527IBA 12/2017
1	Sunitinib (Sutent)FDA Link 01/2011
1	Growth Factor ReceptorsIBA 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009
1	Etanercept (Enbrel)FDA Link 07/2009
1	cixutumumabIBA 06/2009
1	Insulin (Novolin)FDA Link 06/2009
1	RWJ 54428IBA 01/2008
1	LigandsIBA 11/2006
1	Cytotoxins (Cytolysins)IBA 11/2006
1	Mitogen-Activated Protein KinasesIBA 11/2006
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2006
1	IMC-18F1IBA 11/2006
1	Levofloxacin (Levaquin)FDA Link 05/2006
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2006
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2005
1	Platelet-Derived Growth Factor alpha ReceptorIBA 03/2005

6	Therapeutics 01/2011 - 04/2006